$2.63 -0.02 (-0.76%) Endocyte Inc - NASDAQ

Dec. 2, 2016 | 04:00 PM

Quotes

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Last Trade: 2.63
Trade Time: Dec 02 04:00 PM Eastern Daylight Time
Change: -0.02 (-0.76%)
Prev Close: 2.65
Open: 2.67
Bid: 2.63
Ask: 2.64
  1. No results found.
  1. 8 Stocks Moving In Wednesday's After-Hours Session

    Benzinga | Jan. 20, 2016 | 16:59PM EST
  2. Benzinga's Top #PreMarket Gainers

    Benzinga | Sep. 8, 2015 | 07:15AM EST
  3. Endocyte Announces Vintafolide Plus Docetaxel Improved Overall Survival by 2.7 Months in NSCLC

    Benzinga | Sep. 7, 2015 | 14:50PM EST
  4. Benzinga's Top Downgrades

    Benzinga | Sep. 30, 2014 | 08:00AM EST
  5. Brean Capital Downgrades Endocyte To Hold

    Benzinga | Sep. 30, 2014 | 07:34AM EST
  6. Morning Market Movers

    Benzinga | Sep. 29, 2014 | 08:36AM EST
  7. Palo Alto Networks Adds Stanley J. Meresman To Its Board

    Benzinga | Sep. 22, 2014 | 15:04PM EST
  8. Apple Unveils Watch, Larger iPhones; Francesca's Shares Drop After Downbeat Results

    Benzinga | Sep. 9, 2014 | 14:58PM EST
  9. Endocyte Spiked Sharply On Rumored Resumption Of Cancer Drug Trial

    Benzinga | Jun. 30, 2014 | 14:49PM EST
  10. Morning Market Losers

    Benzinga | Jun. 18, 2014 | 08:44AM EST
  11. Benzinga's Top #PreMarket Losers

    Benzinga | Jun. 18, 2014 | 07:12AM EST
  12. Endocyte

    IBD | May. 2, 2014 | 17:58PM EST
  13. Market Wrap For May 2: Markets Slip On Ukraine Tensions Despite Positive Jobs Data

    Benzinga | May. 2, 2014 | 15:58PM EST
  14. Mid-Afternoon Market Update: Markets Shrug Off Strong Jobs Number; Focus On Ukraine

    Benzinga | May. 2, 2014 | 14:44PM EST
  15. Merck, Endocyte Stop Trial Of Ovarian Cancer Drug

    IBD | May. 2, 2014 | 10:09AM EST
Trading Center